NAVCO Pharmaceuticals Inc's market cap is currently C$254.03K. The company's EPS TTM is C$0; its P/E ratio is 0.63; NAVCO Pharmaceuticals Inc is scheduled to report earnings on August 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23
Jun 23
Jun 22
Jun 21
Jun 20
Currency in USD
NAVCO Pharmaceuticals Inc Earnings and Revenue History
